Àü½ÅÈ«¹Ý·çǪ½º ȯÀÚ¿¡¼ ¹ß»ýÇÑ ÇǸ·¼º °æȺ¹¸·¿° 1¿¹
A Case of Sclerosing Encapsulating Peritonitis Presented with Systemic Lupus Erythematosus
´ëÇÑ·ù¸¶Æ¼½ºÇÐȸÁö 2014³â 21±Ç 1È£ p.30 ~ p.34
¹è»óö(Bae Sang-Chul) - ÀÎÁ¦´ëÇб³ ÀÏ»ê¹éº´¿ø ³»°úÇб³½Ç
¹ÚÁÖÇö(Park Joo-Hyun) - ÀÎÁ¦´ëÇб³ ÀÏ»ê¹éº´¿ø ³»°úÇб³½Ç
ÀåÇѾó(Chang Han-Eol) - ÀÎÁ¦´ëÇб³ ÀÏ»ê¹éº´¿ø ³»°úÇб³½Ç
ÀÌÁÖÇö(Lee Joo-Hyun) - ÀÎÁ¦´ëÇб³ ÀÏ»ê¹éº´¿ø ³»°úÇб³½Ç
±èÀ¯¼±(Kim You-Sun) - ÀÎÁ¦´ëÇб³ ÀÏ»ê¹éº´¿ø ³»°úÇб³½Ç
³ªÁ¾Ãµ(Nah Jong-Chun) - ÀÎÁ¦´ëÇб³ ¼¿ï¹éº´¿ø ³»°úÇб³½Ç
À±º¸¿µ(Yoon Bo-Young) - ÀÎÁ¦´ëÇб³ ÀÏ»ê¹éº´¿ø ³»°úÇб³½Ç
Abstract
Sclerosing encapsulating peritonitis (SEP) is characterized by peritoneal fibrosis and adhesion of the peritoneum with the loops of the small intestine. Although the prevalence is low, most cases are caused by peritoneal dialysis, in-fection, medication, systemic lupus erythematosus (SLE), and intra-abdominal neoplasm. We describe a 22-year old man who was presented with abdominal pain and dis-tension, which were attributed to SLE with peritonitis. He had no specific history of previous medical illness and per-itoneal dialysis. He was treated with intravenous high dose methylprednisolone 1 g/day for 3 days, followed by intra-venous methylprednisolone 1 mg/kg daily and immunoglo-bulin. However, his symptoms did not improve. Eventual-ly, a laparoscopic biopsy was performed for an accurate diagnosis. The histopathologic findings were presented in accordance to the typical characteristics of SEP. In spite of medical treatment, he did not show an improvement of clinical symptoms and radiologic findings. As a result, he died from nutritional deficiency, upper gastrointestinal bleeding, and congestive heart failure.
Å°¿öµå
Systemic lupus erythematosus, Sclerosing en-capsulating peritonitis
KMID :
0388220140210010030
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸
À¯È¿¼º°á°ú(Recomendation)